National Survey on Clinical Pharmacy Services of Second-level Hospitals in China: Part 1. Introduction of Survey and Basic Conditions of Clinical Pharmacy Service Provision
XI Xiao-yu1, YAO Dong-ning2, HUANG Yuan-kai1, LU Meng-qing1, WANG Xiao-jing3, WANG Yi-tao2, YAO Wen-bing1*
1. National Development Research Center of Licensed Pharmacist, China Pharmaceutical University, Nanjing 211198, China; 2. Institute of Chinese Medical Sciences, University of Macau, Macau SAR999078, China; 3. Chinese Pharmaceutical Association, Beijing 100022, China
Abstract��OBJECTIVE To obtain data related to clinical pharmacy services of second-level hospitals,find and explore problems in the service system,based on which provide realistic reference for the formulation of relevant policies and norms in clinical pharmaceutical service.METHODS Field interview and survey were conducted to collect data on management system construction,hardware & facility equipment and professional staffing, etc. which was analyzed with descriptive statistics tools.RESULTS The results show that 78.1% of the hospital within the sample established clinical pharmacist performance appraisal systems and had management system construction, but only 9.8% of the hospital��s clinical pharmacy services were charged. In terms of hardware & facility equipment, 60.6% of the hospitals applied rational drug use software systems. In terms of professional staffing, each 100 beds were equipped with an average of 5.7 technical pharmaceutical professionals and an average 3.4 full-time clinical pharmacists; however, dispensing remained main duty of technical pharmaceutical professionals.CONCLUSION There are already certain conditions for anagement system construction,hardware & facility equipment and professional staffing of second-level hospitals in China, but they require further improvement based on the current need for medical services.
ϯ����, Ҧ����, ��Ԫ��, ¬����, �����, ��һ��, Ҧ�ı�. �ҹ�����ҽԺ�ٴ�ҩѧ������״�������о�(һ):�о���鼰�ٴ�ҩѧ���������������[J]. �й�ҩѧ��־, 2018, 53(23): 2058-2064.
XI Xiao-yu, YAO Dong-ning, HUANG Yuan-kai, LU Meng-qing, WANG Xiao-jing, WANG Yi-tao, YAO Wen-bing. National Survey on Clinical Pharmacy Services of Second-level Hospitals in China: Part 1. Introduction of Survey and Basic Conditions of Clinical Pharmacy Service Provision. Chinese Pharmaceutical Journal, 2018, 53(23): 2058-2064.
ELENBASS R M,WORTHEN D B. Transformation of a profession:an overview of the 20th century. Pharm Hist, 2009, 51(4):151-182.
[2]
HERLER C D, STRAND L M. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm, 1990, 47(3):533-543.
[3]
BRODIE D C, BENSON R A. The evolution of the clinical pharmacy concept. Drug Intell Clin Pharm, 1976, 10(9):506-510.
[4]
ASHP guidelines on a standardized method for pharmaceutical care. American Society of Health-System Pharmacists. AJHP, 1996, 53(14):1713-1716.
[5]
ACCP. The definition of clinical pharmacy. Pharmacotherapy, 2008, 28(6):816-817.
[6]
HELLING D K, JOHNSON S G. Defining and advancing ambulatory care pharmacy practice:it is time to lengthen our stride. AJHP, 2014, 71(16):1348.
[7]
KIMBERLY K S, EMILY A P, HANNAH K S, et al. Development and practice of clinical pharmacy in the United States. J China Pharm(�й�ҩ��), 2015, 26(26):3601-3611.
[8]
YAN Y, ZHANG J Y, LIU J, et al. Development of laws and regulations for clinical pharmacist in USA and Japan and its enlightenment for China. China Pharm(�й�ҩʦ), 2016, 19(11):2128-2130.
[9]
LIANG H P, ZHANG X P. Theanalysis and countermeasure of the developing course of pharmaceutical cares in our country. Med Soc(ҽѧ�����), 2010, 23(5):43-45.
[10]
Women��s and Children��s Health Care Department. Guidance of general office of the state conncil on adviving the construction of hierachical medical treatment system. Chin J Rural Med Pharm(�й����ҽҩ), 2015,(20):86-88.
[11]
GALT K A. The need to define "care" in pharmaceutical care: an examination across research, practice and education. Am J Pharm Educ, 2000, 64(3):223-233.
[12]
NAHATA M C. Pharmaceutical care research and pharmacy practice. Chair report for the 1999/2000 Research and Graduate Afairs Commite. Am J Pharm Educ, 2000, 64(1):24-29.
[13]
CHOBANIAN A V, BAKRIS G L, BLACK H R, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. Acc Curr J Review, 2003, 12(4):31-32.
[14]
MCDONOUGH R P, DOUCETTE W R. Drug therapy management: an empirical report of drug therapy problems, pharmacists�� interventions, and results of pharmacists�� actions. J Am Pharm Assoc, 2003, 43(4):511-518.
[15]
SALGADO T M, MOLES R, BENRIMOJ S I, et al. Exploring the role of pharmacists in outpatient dialysis centers: a qualitative study of nephrologist views. Nephrol Dial Transplant, 2013, 28(2):397-404.
[16]
RUTTER P R, HUNT A J, JONES I F. Exploring the gap: community pharmacists�� perceptions of their current role compared with their aspirations. Int J Pharm Prac, 2015, 8(3):204-208.
[17]
ZHANG D D, YANG Q Y, JIN H Y, et al. Investigation and analysis of clinical pharmaceutical care requirements of doctors, nurses and patients. J China Pharm(�й�ҩ��), 2013, 24(20):1839-1842.
[18]
XIONG G C. Practice and investigation on clinical pharmacy services. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2015, 35(16):1512-1514.
[19]
CHEN W Y, CAI W M, MA G. Investigation of cognition and demand of patients and their families on clinical pharmacists and pharmaceutical services. Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2017, 37(24):2490-2495.
[20]
LI J J, YU H X, TANG L, et al. Cost-effectiveness analysis of clinical pharmaceutical care in helicobacter pylori eradication of peptic ulcer outpatients. Chin Pharm J(�й�ҩѧ��־), 2017, 52(23):2126-2131.
[21]
LONG J L, LI R G. The role of clinical pharmacy in second-level hospitals. Guide Chin Med(�й�ҽҩָ��), 2015, 13(4):290-291.
[22]
XING Y, LI X. Investigation and analysis on current situation of implementation of clinical pharmacy among tertiary polyclinics. Acta Univ Med Nanjing(Soc Sci) (�Ͼ�ҽ�ƴ�ѧѧ��:����ѧ��), 2016, 16(1):10-14.
[23]
ZHANG C L. Survey and analysis on current situation of implementation of clinical pharmacy among tertiary polyclinics. J Clin Med Liter(Electr Ed)(�ٴ�ҽҩ��������־), 2016, 3(22):4390-4392.
[24]
XI X Y, YAO D N, HUANG Y K, et al. National survey on clinical pharmacy services of tertiary hospitals in China:part 1. Introduction of survey and basic conditions of clinical pharmacy service provision. Chin Pharm J(�й�ҩѧ��־), 2017, 52(19):1746-1752.
[25]
ESS S M, SCHNEEWEISS S, SZUCS T D. European healthcare policies for controlling drug expenditure. Pharmacoeconomics, 2003, 21(2):89.
[26]
Clinical Practice Affairs Committee of the American College of Clinical Pharmacy. Minimum practice standards for clinical pharmacy specialists with interpretation for organized health-care settings.1985-86. Drug Intell Clin Pharm, 1987, 21(7-8):645-647.
[27]
The ACCP Clinical Practice Affairs Committee. Practice guidelines for pharmacotherapy specialists. A position statement of the American College of Clinical Pharmacy. 1989-1990. Pharmacotherapy, 1990, 10(4):308-311.
[28]
American College of Clinical Pharmacy. Template for the evaluation of a clinical pharmacist. Pharmacotherapy, 1993, 13(6):661-667.
[29]
American Society of Health-System Pharmacists. ASHP guideline: minimum standard for pharmaceutical services in ambulatory care. AJHP, 1999, 56(17):1744-1753.
[30]
LISTED N. ASHP Guidelines: minimum standard for pharmacies in hospitals. AJHP, 2013, 70(18):1619-1630.
[31]
TANG G, LI D W, YUAN S Z. The good pharmacy work specification (2005 Edition) (1). Chin J Hosp Pharm(�й�ҽԺҩѧ��־), 2006, 26(5):503-506.
[32]
Pharmacy regulations for medical institutions. Adverse Drug Reaction J, 2011, 13(2):105-108.
[33]
XIE H Y, LEI X F, LI J T, et al. Value of pharmaceutical care of pharmacists in pharmaceutical services fee. J China Pharm(�й�ҩ��), 2011, 22(17):1550-1552.
[34]
BOND C A, RAEHL C L. Clinical pharmacy services, pharmacystaffing, and hospital mortality rates. Pharmacotherapy, 2012,27(4):481-193.
[35]
PHARMACY A C O C, GUBBINS P O, MICEK S T, et al. Innovation in clinical pharmacy practice and opportunities for academic-practice partnership. Pharmacotherapy, 2014, 34(5):45-54.
2018, Vol. 53 
